Safety Study of SLV213 for the Treatment of COVID-19.
Clinical trial NCT06146374 · TERMINATED
Trial details
- NCT number
- NCT06146374
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-09
- Primary completion
- 2024-07-08
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.